Side by side
Discuss vs DrugPatentWatch
Both stand on market research software. Which one you can start free with, which one lets you read the code, and what each costs once you pay.
Paid AndroidAPIiPhone+1
Choose Discuss if your team needs multiple ways to gather research and AI-assisted analysis in one platform. Its repository and research services may also suit teams handling ongoing studies. Look elsewhere if you need a free plan or published pricing before contacting a provider.
Visit Discuss Paid APIWeb
DrugPatentWatch combines broad pharmaceutical patent coverage with research, alerts, exports, and API delivery. Its paid plans and Starter limits make the plan details important before subscribing.
Visit DrugPatentWatchThe facts
| Discuss | DrugPatentWatch | |
|---|---|---|
| Free plan | No | No |
| Open source | Not published | Not published |
| Runs on | Android, API, iPhone, Web | API, Web |
| Lowest paid plan | Free or on request | Starter: $8,000 a year |
| Plans published | 4 | 6 |
| Maker | Not published | Not published |
| Website | discuss.io | drugpatentwatch.com |
| On market research software | #31 of 59 | #35 of 59 |
Discuss: what it does well
- Supports human-led and AI-moderated interviews, video feedback and uploads.
- AI analysis produces summaries, themes, quotes and highlight reels.
- Discuss Intelligence lets teams query research they already own.
- Plans support unlimited users and include 100 files and 50 GB.
- Lists panel access, advanced segmentation and advanced reporting.
What to know first
- There is no free plan.
- Pricing is available on request.
- Recruiting, translation and reports are add-ons on several plans.
DrugPatentWatch: what it does well
- Coverage spans patents in 134 countries
- Tracks FDA exclusivities and litigation
- Deep Research Engine provides forecasts
- Professional includes data export
- API offers multiple delivery formats
What to know first
- No free plan or free trial
- Starter has limited monthly searches
- Starter has no export or email alerts
- Professional is single-user access
Alternatives to Discuss Alternatives to DrugPatentWatch The whole list